University of Hertfordshire   Report issue

Academic/Hospital Phase 4
Founded: Hertfordshire United Kingdom (1948)

Organization Overview

First Clinical Trial
2016
NCT02999256
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

University of Hertfordshire

Active Ingredients

Drugs in Phase 4 Trials (3)

clopidogrel (plavix) (1 trial)

rivaroxaban (xarelto) (1 trial)

ticagrelor (brilinta) (1 trial)

Drugs in Other Trials (2)

cherry (4 trials)

peppermint extract (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 5